Navigation Links
OxThera coordonne le projet Elimox du 7e PC - 2,19 millions EUR dédiés au développement d'un médicament pour traiter l'hyperoxalurie
Date:9/24/2013

;Recherche au profit de groupes particuliers - Recherche au profit des PME ». Le consortium comprend les 12 partenaires suivants : OxThera AB (Suède), Cobra Biologics Ltd (Royaume-Uni), SymbioPharm GmbH (Allemagne), Ergomed Clinical Research Ltd (Royaume-Uni), Universitätsklinikum Bonn (Allemagne), Hospices civils de Lyon (France), University College London Hospitals NHS Foundation Trust (Royaume-Uni), Galenica AB (Suède), K.A.B.S. Laboratories Inc. (Canada), Medizinisches Versorgumszentrum Institute für Microökologie (Allemagne), TNO (Pays-Bas) et Bio-Images Research Ltd (Royaume-Uni).

À propos de l'hyperoxalurie primaire

L'hyperoxalurie primaire est un trouble génétique autosomal inné rare qui conduit à des élévations marquées des taux d'oxalate endogène dans le plasma et l'urine. Il existe un grand besoin médical insatisfait en termes de traitements efficaces de l'hyperoxalurie. Le seul remède disponible actuellement est la greffe combinée de foie et de rein.

------------------------------------------------

Cette étude a été financée par le septième programme-cadre de l'Union européenne géré par l'Agence exécutive pour la recherche (AER) http://ec.europa.eu/research/rea (FP7/2007-2013) dans le cadre de la convention de subvention no FP7-SME-2013.

Il n'existe aucun accord commercial anticipé susceptible d'imposer des limites à l'exploitation, aux informations ou aux inventions ultérieures générées par ce projet.

Pour tout complément d'information, veuillez contacter :

Elisabeth Lindner, coordinatrice du projet Elimox, tél. : +46-8-660-02-23, e-mail : '/>"/>

SOURCE OxThera
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OxThera stärker patentportfölj för särläkemedel - Primär hyperoxaluri
2. OxThera stärkt sein Patentportfolio für primäre Hyperoxalurie, eine seltene Krankheit
3. OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria
4. Bausch + Lomb soumet une déclaration denregistrement pour un projet doffre publique initiale
5. New Vision Hope For Millions Undergoing Cataract Surgery
6. Producer Austin Chapman Reaches Millions with Inspiring Story on Hearing Loss; Launches Contest in Partnership with Phonak
7. Philips ermöglicht noch besseren Zugang zu Behandlungen für häufige Todesursache in den USA durch Bereitstellung seines einmillionsten AED
8. Info Graphic: Middle managers are frozen by information overload, costing companies millions
9. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
10. Millions Around the World to Have Access to Low-Cost HIV Test by 2013
11. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... is expected to reach USD 24.7 billion by ... View Research Inc. Growing prevalence of neurological and ... equipments market over the forecast period. The presence ... and cryotherapy, advancement in the technologies coupled with ...
(Date:8/3/2015)... 3, 2015 Biosensors International Group, Ltd. ... BIOS.SI; SGX: B20), a developer, manufacturer and marketer ... for its first fiscal quarter ended 30 June ... and Recent Developments: , Biosensors ... cost structure, driven by lower operating expenses and ...
(Date:8/3/2015)... , Aug. 3, 2015  CytomX, a ... of cancer, today announced the promotion of several ... Debanjan Ray , who previously served as vice ... been promoted to senior vice president of corporate ... Ray held positions as the vice president of ...
Breaking Medicine Technology:Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3
... N.J., Jan. 19, 2011 Today, Novo Nordisk announced ... for the Eastern District of Michigan issued an adverse ... US Patent No. 6,677,358. The district court ruled that ... and metformin for the treatment of type 2 diabetes, ...
... Progressive Medical, Inc., a leading pharmacy benefit manager and ... no-faulty auto industries, has named Kevin Banion as chief ... as president of Progressive Medical. This strategic move for ... Bianconi recently announced that he will serve as chairman ...
Cached Medicine Technology:Kevin Banion Named CEO of Progressive Medical, Inc. 2
(Date:8/3/2015)... ... ... Bayer has agreed to pay $56.9 million to set up a settlement program ... suffered an arterial blood clot including stroke and heart attack. The litigation involving product ... ongoing for well-over five years. In 2009, lawsuits filed against Bayer involving Yaz, Yasmin ...
(Date:8/3/2015)... ... 03, 2015 , ... Pitt Researchers to Monitor Resistance to ... School of Medicine are leading a five-year, $5 million initiative to monitor drug ... A cooperative agreement awarded by the U.S. Agency for International Development (USAID), will ...
(Date:8/3/2015)... ... 03, 2015 , ... A recent survey by the ... Hispanics believe people can positively affect their diabetes, few look beyond diet changes ... diet changes was important. Far fewer participants mentioned the need for exercise (30%), ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dental practice in Los Angeles , Sunset ... people know that general health emergencies, such as broken arms or a heart attack, ... where to turn to during a dental emergency. This is important, because dental trauma ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... The art ... experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely ... has decided to share her cookbook Recipes from My Persian Kitchen with the world. ...
Breaking Medicine News(10 mins):Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2
... University determined that immune responses to the tetanus vaccine ... (MTX) was compared with MTX alone in patients with ... (Pneumovax pneumonia vaccine), however, were reduced in RA patients ... published in the January 2010 issue of Arthritis ...
... SODA project has created a service-oriented ecosystem for ... software components in even low-cost devices in the ... of device to communicate using the same language ... will be in a wide range of applications ...
... and others interested in the chemical sciences are invited ... Chemical Society (ACS) Webinars, Your Career Matters! featuring speakers ... science and engineering professionals. Scheduled for Thursday, Jan. ... webinar will feature ACS President Joseph S. Francisco, Ph.D., ...
... ,A new study shows that poor lung function during ... including birth weight, height, and gender. Researchers from Newcastle University ... all aged 14 years. Follow-up data also were obtained for ... showed that several factors were related to poorer lung function ...
... Mayo Clinic research study published in the January issue of ... that St. John,s wort is not an effective treatment for ... treat IBS, to date, no study has examined the success ... IBS. "Our study investigated if herbal antidepressants such as ...
... of a neuronal protein, researchers halted the growth of ... findings are reported online in the Journal of ... Formerly known for its effects on neuronal growth, ... produced by cells in human blood vessels. By diminishing ...
Cached Medicine News:Health News:Immune responses to tetanus vaccine unchanged for RA patients on rituximab 2Health News:Service-oriented ecosystem enables low cost devices to form interactive 'web of objects' 2Health News:Service-oriented ecosystem enables low cost devices to form interactive 'web of objects' 3Health News:ACS Webinar features tips for using a chemistry degree in finding career opportunities 2Health News:News briefs from the January issue of Chest 2Health News:St. John's wort not helpful treatment for irritable bowel syndrome, Mayo Clinic researchers say 2
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
... Surgical Hemostats First Stop absorbable collagen ... that offers superior handling and removal characteristics. ... and tailored to fit the wound. FirstStop ... can easily be peeled away after hemostasis ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: